Pfizer Reiterated at Buy and 2 Analyst-Reiterated Ratings to See Now

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on October 5th.

Pfizer (NYSE:PFE): MKM Partners reiterated its rating of Buy for this company and changed its price target from $27 to $29.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

PPL Corp (NYSE:PPL): Argus reiterated its rating of Buy for this company and changed its price target from $31 to $33.

Datalink (NASDAQ:DTLK): Canaccord Genuity reiterated its rating of Buy for this company and changed its price target from $12 to $10. Needham reiterated its rating of Buy for this company and changed its price target from $12.5 to $11.

Don’t Miss: Vringo to Google: We Have Cash!


More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business